MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijc.34780

Медицинская библиотека · International journal of cancer · 2023

Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.

Rijken Anouk, Pape Marieke, Simkens Geert A, de Hingh Ignace H J T, Luyer Misha D P, van Sandick Johanna W, van Laarhoven Hanneke W M, Verhoeven Rob H A, van Erning Felice N

СтатьяПеревод пока не подготовлен

Аннотация

The aims of this study were to investigate incidence, risk factors and treatment of synchronous or metachronous peritoneal metastases (PM) from gastric cancer and to estimate survival of these patients using population-based data. Patients diagnosed with gastric cancer in 2015 to 2016 were selected from the Netherlands Cancer Registry. The incidence of synchronous and metachronous PM were calculated. Multivariable regression analyses were performed to identify factors associated with the occurrence of PM. Treatment and survival were compared between patients with synchronous and metachronous PM. Of 2206 patients with gastric cancer, 741 (34%) were diagnosed with PM. Of these, 498 (23%) had synchronous PM. The cumulative incidence of metachronous PM in patients who underwent potentially curative treatment (n = 675) was 22.8% at 3 years. A factor associated with synchronous and metachronous PM was diffuse type histology. Patients diagnosed with synchronous PM more often received systemic treatment than patients with metachronous PM (35% vs 18%, respectively, P < .001). Median overall survival was comparable between synchronous and metachronous PM (3.2 vs 2.3 months, respectively, P = .731). Approximately one third of all patients with gastric cancer are diagnosed with PM, either at primary diagnosis or during 3-year follow-up after potentially curative treatment. Patients with metachronous PM less often received systemic treatment than those with synchronous PM but survival was comparable between both groups. Future trials are warranted to detect gastric cancer at an earlier stage and to examine strategies that lower the risk of peritoneal dissemination. Also, specific treatment options for patients with gastric PM should be further investigated.

Для цитирования: Rijken Anouk, Pape Marieke, Simkens Geert A, de Hingh Ignace H J T, Luyer Misha D P, van Sandick Johanna W, van Laarhoven Hanneke W M, Verhoeven Rob H A, van Erning Felice N. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.. International journal of cancer. 2023. DOI: 10.1002/ijc.34780.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.